Medtronic plc (MDT) · Insider trading

What Medtronic's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$8.92M

3 insiders, 3% under a plan

Net, 12 months

−$8.92M

bought less sold

Latest filing

2026-09-17

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $5.13M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Kiil Harry SkipEVP & President Cardiovascular	–	$6.40M	10	2026-09-16	42,186
Smith Gregory LEVP Global Ops & Supply Chain	–	$3.06M	7	2025-11-19	51,830
Wall Brett A.EVP & Pres Neuroscience	–	$1.91M	3	2025-01-24	40,979
Jellison William RDirector	$462,750	–	2	2025-08-25	5,000
Walter Matthew R.SVP, Chief HR Officer	–	$257,931	1	2026-07-08	35,694

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-09-16	Kiil Harry SkipEVP & President Cardiovascular	Sale	1,483	93.65	$138,883	42,186	Form 4
2026-07-08	Walter Matthew R.SVP, Chief HR Officer	Saleplan	3,102	83.15	$257,931	35,694	Form 4
2026-06-08	Kiil Harry SkipEVP & President Cardiovascular	Sale	3,961	80.44	$318,623	37,455	Form 4
2026-06-08	Kiil Harry SkipEVP & President Cardiovascular	Sale	228	80.45	$18,343	37,227	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Sale	1,648	97.86	$161,273	83,644	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Sale	30,568	97.66	$2.99M	53,076	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Sale	19,255	97.77	$1.88M	33,821	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Sale	668	97.83	$65,350	33,153	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Sale	385	97.82	$37,661	32,768	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	24,186	101.93	$2.47M	51,830	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	1,942	101.99	$198,065	49,888	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	1,995	102.03	$203,550	47,893	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	825	102.04	$84,183	47,068	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	227	102.05	$23,165	46,841	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	325	102.06	$33,170	46,516	Form 4
2025-11-19	Smith Gregory LEVP Global Ops & Supply Chain	Sale	500	102.08	$51,040	46,016	Form 4
2025-09-03	Kiil Harry SkipEVP & President Cardiovascular	Sale	8,405	91.58	$769,730	35,815	Form 4
2025-09-03	Kiil Harry SkipEVP & President Cardiovascular	Sale	200	91.59	$18,318	35,615	Form 4
2025-08-25	Jellison William RDirector	Buy	2,500	92.37	$230,925	5,000	Form 4
2025-08-22	Jellison William RDirector	Buy	2,500	92.73	$231,825	2,500	Form 4
2025-01-24	Wall Brett A.EVP & Pres Neuroscience	Saleplan	12,437	90.00	$1.12M	40,979	Form 4
2025-01-08	Wall Brett A.EVP & Pres Neuroscience	Saleplan	6,850	80.41	$550,808	43,708	Form 4
2025-01-08	Wall Brett A.EVP & Pres Neuroscience	Saleplan	3,000	80.41	$241,230	40,708	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

71 × shares withheld for tax44 × grant or award26 × option exercise4 × gift

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-09-15	Blomquist Denise L.Chief Accounting Officer	Gift G	−600	–	16,398	Form 4
2026-08-20	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−1,084	92.30	116,336	Form 4
2026-08-03	Martha GeoffreyDirector, Chairman and CEO	Grant or award A	+41,533	–	327,866	Form 4
2026-08-03	Kiil Harry SkipEVP & President Cardiovascular	Grant or award A	+9,230	–	43,669	Form 4
2026-08-03	Quinn MichelleEVP, GC and Secretary	Grant or award A	+6,346	–	26,721	Form 4
2026-08-03	Marinaro MichaelEVP, Pres MedSurg and Americas	Grant or award A	+10,960	–	71,273	Form 4
2026-08-03	Marinaro MichaelEVP, Pres MedSurg and Americas	Grant or award A	+46,147	–	117,420	Form 4
2026-08-03	Walter Matthew R.SVP, Chief HR Officer	Grant or award A	+5,769	–	39,928	Form 4
2026-08-03	Pieton ThierryEVP & Chief Financial Officer	Grant or award A	+11,537	–	49,645	Form 4
2026-08-03	Blomquist Denise L.Chief Accounting Officer	Grant or award A	+2,337	–	16,998	Form 4
2026-08-03	Thompson KweliEVP & President, Neuroscience	Grant or award A	+6,923	–	35,390	Form 4
2026-07-31	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−15,810	85.39	286,333	Form 4
2026-07-31	Kiil Harry SkipEVP & President Cardiovascular	Shares withheld for tax F	−3,074	85.39	34,439	Form 4
2026-07-31	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−3,356	85.39	60,313	Form 4
2026-07-31	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−1,675	85.39	34,159	Form 4
2026-07-31	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−212	85.39	14,661	Form 4
2026-07-31	Thompson KweliEVP & President, Neuroscience	Shares withheld for tax F	−1,739	85.39	28,467	Form 4
2026-07-28	Quinn MichelleEVP, GC and Secretary	Shares withheld for tax F	−2,069	86.88	20,375	Form 4
2026-06-05	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−237	83.32	14,737	Form 4
2026-06-04	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−41,936	83.32	301,163	Form 4
2026-06-04	Kiil Harry SkipEVP & President Cardiovascular	Shares withheld for tax F	−6,817	83.32	41,416	Form 4
2026-06-04	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−7,471	83.32	63,122	Form 4
2026-06-04	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−2,840	83.32	38,689	Form 4
2026-05-26	Wall Brett A.EVP & Pres Neuroscience	Option exercise M	+26,907	–	82,183	Form 4
2026-05-26	Martha GeoffreyDirector, Chairman and CEO	Option exercise M	+94,963	–	343,099	Form 4
2026-05-26	Kiil Harry SkipEVP & President Cardiovascular	Option exercise M	+15,195	–	48,233	Form 4
2026-05-26	Marinaro MichaelEVP, Pres MedSurg and Americas	Option exercise M	+18,994	–	70,593	Form 4
2026-05-26	Walter Matthew R.SVP, Chief HR Officer	Option exercise M	+9,149	–	41,529	Form 4
2026-05-26	Blomquist Denise L.Chief Accounting Officer	Option exercise M	+1,712	–	14,974	Form 4
2026-05-01	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−35	80.00	32,380	Form 4
2026-04-28	Arnold CraigDirector	Shares withheld for tax F	−207	81.90	42,185	Form 4
2026-04-28	Hogan Randall JDirector	Shares withheld for tax F	−207	81.90	48,998	Form 4
2026-04-28	Donnelly Scott CDirector	Shares withheld for tax F	−207	81.90	23,679	Form 4
2026-04-28	Powell Kendall JDirector	Shares withheld for tax F	−207	81.90	51,380	Form 4
2026-04-28	Fonseca LidiaDirector	Shares withheld for tax F	−207	81.90	7,644	Form 4
2026-04-28	Lofton Kevin EDirector	Shares withheld for tax F	−207	81.90	10,140	Form 4
2026-04-28	Nabel Elizabeth GDirector	Shares withheld for tax F	−207	81.90	19,584	Form 4
2026-04-28	Lewis Gregory PDirector	Shares withheld for tax F	−207	81.90	5,754	Form 4
2026-04-28	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−318	81.90	13,262	Form 4
2026-04-27	Arnold CraigDirector	Grant or award A	+2,111	–	42,392	Form 4
2026-04-27	Hogan Randall JDirector	Grant or award A	+2,111	–	49,205	Form 4
2026-04-27	Jellison William RDirector	Grant or award A	+1,444	–	6,444	Form 4
2026-04-27	Donnelly Scott CDirector	Grant or award A	+2,111	–	23,886	Form 4
2026-04-27	Powell Kendall JDirector	Grant or award A	+2,111	–	51,587	Form 4
2026-04-27	Fonseca LidiaDirector	Grant or award A	+2,111	–	7,851	Form 4
2026-04-27	Lofton Kevin EDirector	Grant or award A	+2,111	–	10,347	Form 4
2026-04-27	Groetelaars John PDirector	Grant or award A	+1,444	–	1,444	Form 4
2026-04-27	Nabel Elizabeth GDirector	Grant or award A	+2,111	–	19,791	Form 4
2026-04-27	Lewis Gregory PDirector	Grant or award A	+2,111	–	5,961	Form 4
2026-04-27	Blomquist Denise L.Chief Accounting Officer	Grant or award A	+1,508	–	13,580	Form 4
2026-04-27	Lee Joon SupDirector	Grant or award A	+1,803	–	1,803	Form 4
2026-03-03	Pieton ThierryEVP & Chief Financial Officer	Shares withheld for tax F	−2,976	96.71	37,574	Form 4
2026-02-20	Blomquist Denise L.Chief Accounting Officer	Gift G	−340	–	11,966	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Option exercise M	+30,568	93.08	64,984	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Option exercise M	+19,923	87.76	84,907	Form 4
2026-02-19	Kiil Harry SkipEVP & President Cardiovascular	Option exercise M	+385	80.00	85,292	Form 4
2026-01-29	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−148	101.00	12,306	Form 4
2025-12-15	Wall Brett A.EVP & Pres Neuroscience	Shares withheld for tax F	−439	99.87	54,749	Form 4
2025-12-15	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−1,564	99.87	246,393	Form 4
2025-12-15	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−1,371	99.87	50,818	Form 4
2025-12-05	Kiil Harry SkipEVP & President Cardiovascular	Shares withheld for tax F	−1,702	101.36	34,177	Form 4
2025-11-20	Blomquist Denise L.Chief Accounting Officer	Gift G	−170	–	12,357	Form 4
2025-08-20	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−1,052	93.22	51,939	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Option exercise M	+246	–	12,671	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−93	89.34	12,578	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Option exercise M	+58	–	12,636	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−22	89.34	12,614	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−204	89.34	12,410	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Option exercise M	+214	78.00	12,624	Form 4
2025-08-01	Blomquist Denise L.Chief Accounting Officer	Shares withheld for tax F	−196	89.34	12,428	Form 4
2025-08-01	Kiil Harry SkipEVP & President Cardiovascular	Option exercise M	+10,457	–	51,775	Form 4
2025-08-01	Kiil Harry SkipEVP & President Cardiovascular	Shares withheld for tax F	−4,659	89.34	47,116	Form 4
2025-08-01	Kiil Harry SkipEVP & President Cardiovascular	Shares withheld for tax F	−2,896	89.34	44,220	Form 4
2025-08-01	Marinaro MichaelEVP, Pres MedSurg and Americas	Option exercise M	+6,535	–	57,628	Form 4
2025-08-01	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−3,158	89.34	54,470	Form 4
2025-08-01	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−1,741	89.34	52,729	Form 4
2025-08-01	Marinaro MichaelEVP, Pres MedSurg and Americas	Option exercise M	+3,126	78.00	55,855	Form 4
2025-08-01	Marinaro MichaelEVP, Pres MedSurg and Americas	Shares withheld for tax F	−2,864	89.34	52,991	Form 4
2025-08-01	Martha GeoffreyDirector, Chairman and CEO	Option exercise M	+57,724	–	283,700	Form 4
2025-08-01	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−26,323	89.34	257,377	Form 4
2025-08-01	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−13,054	89.34	244,323	Form 4
2025-08-01	Martha GeoffreyDirector, Chairman and CEO	Option exercise M	+40,600	78.00	284,923	Form 4
2025-08-01	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−37,798	89.34	247,125	Form 4
2025-08-01	Smith Gregory LEVP Global Ops & Supply Chain	Option exercise M	+11,328	–	83,071	Form 4
2025-08-01	Smith Gregory LEVP Global Ops & Supply Chain	Shares withheld for tax F	−4,458	89.34	78,613	Form 4
2025-08-01	Smith Gregory LEVP Global Ops & Supply Chain	Shares withheld for tax F	−2,656	89.34	75,957	Form 4
2025-08-01	Wall Brett A.EVP & Pres Neuroscience	Option exercise M	+15,249	–	66,531	Form 4
2025-08-01	Wall Brett A.EVP & Pres Neuroscience	Shares withheld for tax F	−7,744	89.34	58,787	Form 4
2025-08-01	Wall Brett A.EVP & Pres Neuroscience	Shares withheld for tax F	−3,850	89.34	54,937	Form 4
2025-08-01	Walter Matthew R.SVP, Chief HR Officer	Option exercise M	+2,179	–	32,804	Form 4
2025-08-01	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−667	89.34	32,137	Form 4
2025-08-01	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−364	89.34	31,773	Form 4
2025-08-01	Walter Matthew R.SVP, Chief HR Officer	Option exercise M	+963	78.00	32,736	Form 4
2025-08-01	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−879	89.34	31,857	Form 4
2025-07-31	Smith Gregory LEVP Global Ops & Supply Chain	Shares withheld for tax F	−1,630	90.24	71,743	Form 4
2025-07-28	Blomquist Denise L.Chief Accounting Officer	Grant or award A	+2,202	–	12,425	Form 4
2025-07-28	Kiil Harry SkipEVP & President Cardiovascular	Grant or award A	+7,612	–	41,318	Form 4
2025-07-28	Marinaro MichaelEVP, Pres MedSurg and Americas	Grant or award A	+9,786	–	51,093	Form 4
2025-07-28	Martha GeoffreyDirector, Chairman and CEO	Grant or award A	+37,513	–	225,976	Form 4
2025-07-28	Pieton ThierryEVP & Chief Financial Officer	Grant or award A	+8,699	–	39,958	Form 4
2025-07-28	Quinn MichelleEVP, GC and Secretary	Grant or award A	+5,437	–	5,437	Form 4
2025-07-28	Quinn MichelleEVP, GC and Secretary	Grant or award A	+16,310	–	21,747	Form 4
2025-07-28	Smith Gregory LEVP Global Ops & Supply Chain	Grant or award A	+9,786	–	73,373	Form 4
2025-07-28	Wall Brett A.EVP & Pres Neuroscience	Grant or award A	+9,786	–	51,282	Form 4
2025-07-28	Walter Matthew R.SVP, Chief HR Officer	Grant or award A	+4,350	–	30,625	Form 4
2025-06-03	Blomquist Denise L.Chief Accounting Officer	Gift G	−310	–	10,143	Form 4
2025-05-02	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−34	84.85	26,054	Form 4
2025-04-29	Arnold CraigDirector	Shares withheld for tax F	−216	84.60	40,216	Form 4
2025-04-29	Donnelly Scott CDirector	Shares withheld for tax F	−216	84.60	21,630	Form 4
2025-04-29	Fonseca LidiaDirector	Shares withheld for tax F	−216	84.60	5,675	Form 4
2025-04-29	Goldsmith Andrea JoDirector	Shares withheld for tax F	−216	84.60	10,247	Form 4
2025-04-29	Hogan Randall JDirector	Shares withheld for tax F	−216	84.60	47,029	Form 4
2025-04-29	Lewis Gregory PDirector	Shares withheld for tax F	−181	84.60	3,785	Form 4
2025-04-29	Lofton Kevin EDirector	Shares withheld for tax F	−216	84.60	8,171	Form 4
2025-04-29	Nabel Elizabeth GDirector	Shares withheld for tax F	−216	84.60	17,615	Form 4
2025-04-29	Powell Kendall JDirector	Shares withheld for tax F	−216	84.60	48,622	Form 4
2025-04-28	Arnold CraigDirector	Grant or award A	+2,083	84.04	40,432	Form 4
2025-04-28	Donnelly Scott CDirector	Grant or award A	+2,083	84.04	21,846	Form 4
2025-04-28	Fonseca LidiaDirector	Grant or award A	+2,083	84.04	5,891	Form 4
2025-04-28	Goldsmith Andrea JoDirector	Grant or award A	+2,083	84.04	10,463	Form 4
2025-04-28	Hogan Randall JDirector	Grant or award A	+2,083	84.04	47,245	Form 4
2025-04-28	Lewis Gregory PDirector	Grant or award A	+2,083	84.04	3,966	Form 4
2025-04-28	Lofton Kevin EDirector	Grant or award A	+2,083	84.04	8,387	Form 4
2025-04-28	Nabel Elizabeth GDirector	Grant or award A	+2,083	84.04	17,831	Form 4
2025-04-28	Powell Kendall JDirector	Grant or award A	+2,083	84.04	48,838	Form 4
2025-04-28	Blomquist Denise L.Chief Accounting Officer	Grant or award A	+2,975	–	10,453	Form 4
2025-03-03	Pieton ThierryEVP & Chief Financial Officer	Grant or award A	+4,242	–	4,242	Form 4/A
2025-03-03	Pieton ThierryEVP & Chief Financial Officer	Grant or award A	+26,512	–	30,754	Form 4/A
2025-03-03	Marinaro MichaelEVP & President, Surgical OU	Shares withheld for tax F	−575	94.30	40,675	Form 4
2025-01-27	Martha GeoffreyDirector, Chairman and CEO	Option exercise M	+34,741	74.84	216,954	Form 4
2025-01-27	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−30,184	92.46	186,770	Form 4
2025-01-27	Marinaro MichaelEVP & President, Surgical OU	Option exercise M	+2,345	74.84	43,323	Form 4
2025-01-27	Marinaro MichaelEVP & President, Surgical OU	Shares withheld for tax F	−2,073	92.46	41,250	Form 4
2025-01-27	Walter Matthew R.SVP, Chief HR Officer	Option exercise M	+1,337	74.84	26,997	Form 4
2025-01-27	Walter Matthew R.SVP, Chief HR Officer	Shares withheld for tax F	−1,174	92.46	25,823	Form 4
2025-01-24	Wall Brett A.EVP & Pres Neuroscience	Option exercise M	+12,437	78.00	53,416	Form 4
2025-01-21	Corona Gary LouisInterim CFO	Grant or award A	+11,315	–	44,255	Form 4
2025-01-08	Wall Brett A.EVP & Pres Neuroscience	Option exercise M	+6,850	74.84	50,558	Form 4
2024-12-16	Fong Ivan KEVP GENERAL COUNSEL & SECR	Shares withheld for tax F	−532	82.48	54,692	Form 4
2024-12-16	Martha GeoffreyDirector, Chairman and CEO	Shares withheld for tax F	−4,417	82.48	181,326	Form 4
2024-12-16	Salmon SeanEVP & President Cardiovascular	Shares withheld for tax F	−645	82.48	64,722	Form 4
2024-12-16	Wall Brett A.EVP & Pres Neuroscience	Shares withheld for tax F	−645	82.48	43,708	Form 4
2024-12-10	Fong Ivan KEVP GENERAL COUNSEL & SECR	Shares withheld for tax F	−3,009	83.58	55,224	Form 4
2024-12-06	Kirk Jennifer MChief Accounting Officer	Shares withheld for tax F	−646	84.01	28,011	Form 4
2024-12-06	Corona Gary LouisInterim CFO	Shares withheld for tax F	−662	84.01	32,721	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Medtronic's scores and multiples ›